Updated U.S. guidelines on heart health advise more personalized assessment of risk as well as two newer types of cholesterol-lowering drugs for people at particularly high risk of heart attack or stroke.
The recommendations from the American Heart Association and the American College of Cardiology, last issued in 2013, acknowledge recent research showing the benefit of very low levels of “bad” LDL cholesterol, which contributes to fatty plaque buildup and narrowing of arteries.
